The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?
about
Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ systemPancreatic cancer surgery: past, present, and futureEarly detection of pancreatic cancerMicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parametersMethylation of cell-free circulating DNA in the diagnosis of cancerA combination of molecular markers and clinical features improve the classification of pancreatic cysts.CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysisLiver transplant patients have a risk of progression similar to that of sporadic patients with branch duct intraductal papillary mucinous neoplasms.Genomic landscapes of pancreatic neoplasia.PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathwayIdentification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.MiR-1178 promotes the proliferation, G1/S transition, migration and invasion of pancreatic cancer cells by targeting CHIP.BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE studyZidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer.Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stagesSU11274 suppresses proliferation and motility of pancreatic cancer cells.Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinomaPancreatic cancer screening in different risk individuals with family history of pancreatic cancer-a prospective cohort study in Taiwan.The genetic classification of pancreatic neoplasia.Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids.ITGA1 is a pre-malignant biomarker that promotes therapy resistance and metastatic potential in pancreatic cancer.Pancreatic Cancer Chemoprevention Translational Workshop: Meeting ReportAvarol induces apoptosis in pancreatic ductal adenocarcinoma cells by activating PERK-eIF2α-CHOP signaling.Knockdown of glucose-regulated protein 78 enhances poly(ADP-ribose) polymerase cleavage in human pancreatic cancer cells exposed to endoplasmic reticulum stressCombined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer.Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier.Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.Clinical data combined with radiological imaging improves the accuracy of TNM staging of pancreatic body and tail adenocarcinoma.Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective.Pancreatic cancer and associated exosomes.Protein Biomarkers for Early Detection of Pancreatic Ductal Adenocarcinoma: Progress and Challenges.Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer.A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary BiologyCyst Fluid Biomarkers - Diagnosis and Prediction of Malignancy for Cystic Lesions of the PancreasIndividualized metabolic profiling stratifies pancreatic and biliary tract cancer: a useful tool for innovative screening programs and predictive strategies in healthcare
P2860
Q26748510-49F3BDBD-9967-44E9-A231-738A189FCFFEQ26781555-841E1986-83A1-4AE3-AB95-2592F9FF5CCEQ26781558-4427E8ED-4E92-468B-97C6-F11BB750BEE3Q26799779-7FFCD7E3-473F-42DE-943D-8A61CD29F227Q27022231-BF3D76D7-95A8-4B21-B9C5-46736CCFB41EQ28085699-B5A46D4E-5290-4523-AB8B-99B4CDE92894Q30724746-0C3458FC-884A-4C17-A2DA-147F494DF997Q33814832-2156B0D6-F0B2-48CB-A6C8-1903BE2C7582Q35067692-96C90AF8-05EB-4E0A-BF3C-189E7186A3CDQ35170720-41868DD3-6341-402A-8B08-4796B3581868Q35288875-D6683FB7-DF0A-45C1-BF50-2621E273671AQ35551996-1D1A3016-9449-4BC3-87D4-F8E9B6A8DE8AQ35551998-3B066C86-933F-4404-A2F3-1245A3406E4DQ35630278-EA73AFD8-69B1-4568-92D8-630805AEB2C8Q35674606-2FB7E3C4-ACEC-4C2A-9E71-254205210259Q35842473-69CDA5B0-E860-422B-89B5-9692061FBE20Q35904643-0297B7E4-BC18-46BB-BE65-09C2B84C378AQ35944581-272F1A0D-CB87-47B9-8B3E-947C781AFCE6Q36262320-639782B5-908E-493F-80B9-04835E03BFFEQ36747321-D13AEF1B-7200-4D44-850D-3F63600D51EAQ37680013-E65F18D8-C7A0-4BE0-B96F-846DED1AFA52Q38326191-E450BC84-5521-44F7-AD2C-258BDB7181C0Q38550197-354F1CCA-4127-4E39-8E25-1201B2D62EBCQ38601572-7A5C1F2B-BF2C-4D55-93C9-2654A0E00140Q38831886-0FD9CAB9-DA75-4FE0-947C-EAFB2DD6142CQ38884475-A82C174E-8A93-48C6-B836-893F7DD5AD02Q38946261-7D4E4BA6-1E3E-4E14-B432-88B8D9889847Q40056869-49684254-3D0C-4A46-A9F7-014A8C62054EQ40503345-56D77D16-2E3F-4438-B677-361156682B14Q41360172-B118DA0D-C5C0-45AB-B2A1-C1BA8282D364Q42258075-86DC55AB-E0FD-4308-A63D-F1E29A47491FQ42329894-CB8C5D18-74E9-4777-B51C-9C4BD33D10EEQ42373823-F32B63F9-966D-4E52-B46C-C104E80F4797Q48521971-3B96A80B-C4F7-436B-B2DE-8309245FA7ADQ50075097-29E2DB84-8E06-4F1C-A874-B17973560DA4Q52666355-6BEFD926-6FE5-47EF-A256-9D0F609FCD70Q53082215-82321BB5-04EE-4AA0-A992-7364DB1575A9Q54989340-D48CB637-1607-4C8F-9673-26624C487403Q57141737-6C261976-F2EB-44CF-8F78-6DB123CFD835Q58769747-75A52281-CFC0-47B8-8C45-C2E3AA99D33E
P2860
The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The early detection of pancrea ...... curable pancreatic neoplasia?
@ast
The early detection of pancrea ...... curable pancreatic neoplasia?
@en
type
label
The early detection of pancrea ...... curable pancreatic neoplasia?
@ast
The early detection of pancrea ...... curable pancreatic neoplasia?
@en
prefLabel
The early detection of pancrea ...... curable pancreatic neoplasia?
@ast
The early detection of pancrea ...... curable pancreatic neoplasia?
@en
P2093
P2860
P50
P1433
P1476
The early detection of pancrea ...... curable pancreatic neoplasia?
@en
P2093
Alison P Klein
Christopher L Wolfgang
Ihab Kamel
Joseph M Herman
Marcia Irene Canto
Matthew J Weiss
Nickolas Papadopoulos
P2860
P304
P356
10.1158/0008-5472.CAN-14-0734
P407
P50
P577
2014-06-12T00:00:00Z